Chemosuppression of Breast Cancer with Tamoxifen: Laboratory Evidence and Future Clinical Investigations
- 1 January 1988
- journal article
- review article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 6 (5) , 589-595
- https://doi.org/10.3109/07357908809082124
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: A model to study the tumoristatic action of tamoxifenJournal of Steroid Biochemistry, 1988
- Hormone Receptor Assays: Clinical Usefulness in the Management of Carcinoma of the BreastCRC Critical Reviews in Clinical Laboratory Sciences, 1988
- Autocrine and paracrine growth regulation of human breast cancerBreast Cancer Research and Treatment, 1986
- Consensus conference. Adjuvant chemotherapy for breast cancerPublished by American Medical Association (AMA) ,1985
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984
- Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycleEuropean Journal of Cancer and Clinical Oncology, 1983
- Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic miceCancer Letters, 1980
- Oestrogen-responsive human breast cancer in long term tissue cultureNature, 1975
- Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptorPublished by Elsevier ,1975
- Mammary Cancer Induced by a Single Feeding of Polynuclear Hydrocarbons, and its SuppressionNature, 1961